山东痛风石症状及治疗(山东痛风一直隐痛怎么办) (今日更新中)

SAN FRANCISCO, Dec. 8 (Xinhua) -- Twitter on Thursday started to roll out a major redesign of its interface in hopes of simplifying users' experience, as well as new brand pages to strengthen its relationship with advertisers.During a press conference at its new headquarters in San Francisco, Twitter Chief Executive Officer Dick Costolo and co- founder Jack Dorsey unveiled a whole new look of the social networking and microblogging service.According to an introduction video, the new homepage features profile on the left and the timeline on the right, which are flipped from the current positions and take less space than they used to.Three new buttons were also introduced as "Home," "Connect" and "Discover." "Connect" shows users who has mentioned them and suggests some accounts they might want to follow. "When you use Discover, you'll see results reflecting your interests -- based on your current location, what you follow and what's happening in the world," said Twitter.The overhauled interface is only available to a small group of users at first and will be rolled out to all users over the coming months. It will also remain consistent across Twitter's official mobile apps. Twitter has launched a page fly.twitter.com to explain all the changes.Along with the introduction of the redesign, Twitter also announced new brand pages on its platform. A total of 21 brand partners will be included in the initial launch, such as American Express, Best Buy, Bing, Coca-Cola, HP, Disney and Nike.Analysts said Twitter has ambitions to compete with similar brand pages from Facebook and Google+. According to eMarketer, Twitter's global advertising revenue is expected to reach 139.5 million U.S. dollars this year and approach 400 million dollars in 2013.

SAN FRANCISCO, Nov. 11 (Xinhua) -- Facebook is close to a settlement with the U.S. Federal Trade Commission (FTC) over the charges that the world's largest social network misled users about its use of their personal information, the U.S. media reported Friday.The proposed settlement would require Facebook to get users' consent before making "material retroactive changes" to its privacy policies, said a report from The Wall Street Journal, citing people familiar with the talks.The agreement with the FTC is also expected to ripple much farther in the tech industry as more companies are developing programs to observe people's online behavior and profiting from the personal information, such as the target advertisements.With a current 800-million-user base worldwide, Facebook changed its user policy in late 2009 to disclose more of users' personal information without adequate notice, leading to a federal investigation along with mounting complaints online.On Thursday, two U.S. representatives asked the Palo Alto, California-based company to explain a February patent application, saying that it raises alarm bells about how the company tracks users on other websites.Outside the U.S., Facebook is also drawing criticism on its privacy policies in countries with strict privacy laws, such as Germany. On Thursday, German authorities said they are considering suing Facebook over its use of facial recognition technology.In a PBS interview aired earlier this week, Facebook's founder and chief executive officer Mark Zuckerberg and chief operating officer Sheryl Sandberg said the company is focused on privacy, addressing that it gives users the ability to protect their privacy.Zuckerberg said Facebook users volunteer all of their personal information on the social network, unlike other Internet giants and advertising networks that compile information "behind your back."

WASHINGTON, Jan. 1 (Xinhua) -- Twin U.S. spacecraft to study the moon from crust to core put themselves into the lunar orbit on New Year's Eve and New Year's Day, the country's space agency said.The second Gravity Recovery And Interior Laboratory, or GRAIL-B, reached its lunar orbit at 5:43 p.m. EST (2243 GMT) on Sunday, according to the National Aeronautics and Space Administration (NASA).The GRAIL-A started orbiting the moon at 5 p.m. (2200 GMT) Saturday.The insertion maneuvers placed the spacecraft into a near-polar, elliptical orbit with an orbital period of approximately 11.5 hours, NASA said.Over the coming weeks, the GRAIL team will execute a series of burns with each spacecraft to reduce their orbital period to just under two hours. At the start of the science phase in March 2012, the twin GRAILs will be in a near-polar, near-circular orbit with an altitude of about 55 km."NASA greets the new year with a new mission of exploration," Administrator Charles Bolden said in a statement. "The twin GRAIL spacecraft will vastly expand our knowledge of our moon and the evolution of our own planet."During GRAIL's science mission, the two probes will transmit radio signals precisely defining the distance between them. As they fly over areas of greater and lesser gravity caused by visible features such as mountains, craters and masses hidden beneath the lunar surface, the distance between the twin spacecraft will change slightly.Scientists will translate this information into a high-resolution map of the moon's gravitational field.The data will allow scientists to understand what goes on below the lunar surface and increase knowledge of how Earth and its rocky neighbors in the inner solar system developed into the diverse worlds we see today.

WASHINGTON, Oct. 13 (Xinhua) -- U.S. researchers have corrected sickle cell disease in adult laboratory mice that had been bred to have the inherited blood disorder by activating production of a special blood component, according to a study published online Thursday in the journal Science.Sickle cell disease results from an abnormality in hemoglobin, the protein found in red blood cells that is responsible for transporting oxygen throughout the body. People living with sickle cell disease have two copies of an altered gene that produces sickle hemoglobin instead of normal adult hemoglobin. Sickle hemoglobin changes shape after releasing its oxygen, causing the red blood cell to become stiff, misshapen and sticky, and slowing blood flow to tissues. This process damages organs and causes pain.The study tested a new approach to increasing the production of a third form of hemoglobin -- fetal hemoglobin. Production of fetal hemoglobin predominates before birth, but turns off thereafter as adult hemoglobin production takes over. People with sickle cell disease are unable to make normal adult hemoglobin, and instead make sickle hemoglobin starting in infancy.An elevated level of fetal hemoglobin within the red blood cell reduces the tendency of sickle hemoglobin to change the shape of red blood cells. Considerable research has shown that the drug hydroxyurea increases production of fetal hemoglobin and reduces the number of pain crises and other complications of sickle cell disease in adults and children. However, not all patients respond well to hydroxyurea, and adverse side effects are a concern.The current study explores a more targeted approach to increasing fetal hemoglobin production. It builds upon earlier studies that discovered a protein called BCL11A normally suppresses the production of fetal hemoglobin soon after birth. The researchers viewed the BCL11A protein as a target for therapy and decided to see what would happen if they blocked production of the protein.The paper details how the research team silenced the mouse gene that produces the BCL11A protein in mice with sickle cell disease. Silencing the gene turned off production of the BCL11A protein and allowed the adult mice to continue to produce fetal hemoglobin. It appears to have eliminated disease symptoms without affecting other aspects of blood production."This discovery provides an important new target for future therapies in people with sickle cell disease," said Susan Shurin, acting director of the U.S. National Heart, Lung, and Blood Institute, which co-funded the study. "More work is needed before it will be possible to test such therapies in people, but this study demonstrates that the approach works in principle."Approximately 100,000 Americans live with sickle cell disease. It is most prevalent in people of African, Hispanic, Mediterranean, and Middle Eastern descent. There is no widely available cure for sickle cell disease. Bone marrow transplants have cured some patients, but the treatment is not without risk and most patients do not have relatives who can donate compatible and healthy bone marrow to them.

SHANGHAI, Jan. 11 (Xinhua) -- The listed arm of China's biggest train maker, China South Locomotive and Rolling Stock Industry (Group) Corporation (CSR), has been allowed by regulatory authorities to raise 9 billion yuan (1.41 billion U.S. dollars) on the stock market, the company said Wednesday.The Hong Kong- and Shanghai- listed CSR Corp. Ltd. will sell 1.96 billion shares at 4.46 yuan apiece to select investors, it said. But CSR's parent -- state-owned CSR Group -- has agreed to buy no less than 6 billion yuan's worth of the shares, leaving the rest to institutional investors.CSR's net profit growth in the third quarter of 2011 plunged to 9.66 percent year-on-year from a high of 85.08 percent in the first half of 2011 as the country put the brakes on development of the railway sector after a deadly bullet train crash on July 23 that killed 40 people and injured 210 others.The decision to slow the development of high-speed rail lines has led to halts in construction of about 90 percent of ongoing railway projects, or 10,000 km of rail lines across the country, local media reported earlier.CSR is the maker of the bullet trains involved in last July's deadly collision. After the accident, the company's executives bought a combined 540,000 share in August, a move seen as an attempt to bolster battered stock prices.Analysts say the fundraising would help CSR greatly ease its financial burdens. The company earlier pledged to maintain profit growth and its dividend policy to boost investors' confidence.

来源：资阳报